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Abstract
Roux-en-y gastric bypass (RYGB) surgery is associated with dramatic improvements in obesity-
related comorbidity, but also with nutritional deficiencies. Vitamin D concentrations are depressed
in the severely obese, but the impact of weight loss via RYGB is unknown. We determined
associations between adiposity and systemic 25-hydroxyvitamin D (25(OH)D) during weight loss
and the immediate and longer-term effects of RYGB. Plasma 25(OH)D concentrations and fat
mass (FAT) were determined by immunoassay and air displacement plethysmography,
respectively, at 0 (before RYGB surgery), and at 1, 6, and 24 months in severely obese white and
African American (AA) women (n = 20). Decreases in adiposity were observed at 1, 6, and 24
months following RYGB (P < 0.05). Plasma 25(OH)D concentrations increased at 1 month (P =
0.004); a decreasing trend occurred over the remainder months after surgery (P = 0.02). Despite
temporary improvement in vitamin D status, a high prevalence of vitamin D insufficiency was
observed (76, 71, 67, and 82%, at baseline, 1, 6, and 24 months, respectively), and plasma
25(OH)D concentrations were lower in AA compared to white patients (P < 0.05). Strong positive
baseline and 1 month cross-sectional correlations between FAT and plasma 25(OH)D were
observed, which remained after adjustment for age and race subgroup (β = 0.76 and 0.61,
respectively, P = 0.02). In conclusion, 25(OH)D concentrations increased temporarily and then
decreased during the 24 months following RYGB. The acute increase and the positive associations
observed between adipose tissue mass and systemic 25(OH)D concentrations suggest storage in
adipose tissue and release during weight loss.
INTRODUCTION
The epidemic of severe obesity in adults defined by BMI is a major health concern in the
United States. Prevalence has quadrupled from 1976 to 2000 (1,2) and currently 5.7% of the
US population is affected (3). Severe obesity is associated with an increased risk of health
complications such as: cardiovascular disease, diabetes, and cancer (4–6). Bariatric surgery
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is the most efficient method in producing maximum weight loss in severely obese patients
(7). Roux-en-y gastric bypass (RYGB) is a common bariatric procedure which induces food
restriction and as well as malabsorption of macro- and micronutrients. Following RYGB
70% of patients achieve effective weight loss (defined as losing >50% of their excess
weight) and resolution of most obesity-related comorbidities (8), but many patients also
experience nutritional deficiencies including calcium, iron, vitamin B12, and vitamin D (9).
Vitamin D is an essential nutrient that functions in regulating bone metabolism, cell
proliferation, and immunity (10). A high prevalence of vitamin D insufficiency (25(OH)D
<75 nmol/l or 30 ng/ml) is found in the United States (11). Many factors affect vitamin D
status including latitude, dietary intake and use of supplements, intestinal absorption, sun
exposure, and skin color (12).
Past studies have shown decreased levels of serum 25(OH)D in obese individuals, when
compared to lean, showing an inverse relationship between BMI or body fatness and serum
25(OH)D (13–15). One explanation for lower levels of 25(OH)D occurring in obesity is that
vitamin D, a fat soluble molecule, is stored and possibly sequestered in adipose tissue
(16,17). Following ingestion of radiolabeled vitamin D3, high concentrations of the
compound were measured in the adipose tissue of rodents relative to serum and to other
tissues (18). Substantial amounts of 25(OH)D have also been observed in human adipose
tissue (19). Sequestration of vitamin D in adipose tissue is suggested by a single study in
humans in which, following UV irradiation in lean vs. obese subjects, equal amounts of
vitamin D3 were found in skin samples, but serum vitamin D3 concentrations in obese
subjects were reduced (17). In the same study, oral doses of vitamin D2 resulted in lower
serum concentrations of vitamin D2 in obese compared to lean subjects. A recent study, in
which adipose tissue and plasma samples were obtained from severely obese individuals
undergoing bariatric surgery, found a positive relationship between serum and subcutaneous
fat vitamin D3 concentrations (20). Thus the issue of whether vitamin D is stored and then
released or instead sequestered in obese humans warrants further investigation.
Although it is clear that obesity decreases vitamin D concentrations, the potential benefits of
weight loss on vitamin D status have not been shown. Also unknown is the impact of
bariatric surgery on vitamin D status, as the malabsorptive types of bariatric surgery
promote malabsorption of fat soluble nutrients in the small intestine, changes in dietary
intake, and decrease of adipose tissue stores. A high rate of vitamin D deficiency has been
identified in preoperative bariatric surgery patients (21). In that study of 312 patients, 57%
were deficient in vitamin D preoperatively (25(OH)D ≤50 nmol/l). Of the black patients
evaluated, 78% were vitamin D deficient and 37% of the white patients were deficient.
Postoperative bariatric surgery patients have a high prevalence of vitamin D deficiency
(which has been documented as high as 80%) (22–27), but limited prospective studies have
documented both pre- and postoperative levels of 25(OH)D in bariatric surgery patients (27–
29). Also, vitamin D status over several months or years following bariatric surgery
procedures has been little studied. Thus it is unclear whether bariatric surgery improves or
further aggravates the status of vitamin D.
The purpose of this study was to determine plasma 25(OH)D concentrations in a cohort of
white and African-American women undergoing RYGB surgery and followed prospectively
acutely and for up to 24 months. Variables including race, time following surgery, body fat
mass (FAT), regional adiposity, and dietary intake were assessed in order to define the
potential effects of surgical weight loss on vitamin D status.
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The study subjects were 20 severely obese female patients who had RYGB at the Emory
Bariatric Center via RYGB (21). Clinical, psychological, and nutritional evaluations were
performed before surgery. This was longitudinal study in which each patient served as her
own control. Subjects were evaluated at baseline (before surgery) and again at 1, 6, and 24
months postsurgery. Exclusion criteria for this study were (i) male gender, (ii) age <18 years
or >65, (iii) BMI <35 kg/ m2, and (iv) current smoking history. All patients were prescribed
a multivitamin/multimineral regimen following surgery, but dietary and supplement intake,
using 3-day food records, collected at each study visit and analyzed using Food Processor
SQL (ESHA Research, Salem, OR), was monitored only for a subset of consecutively
enrolled subjects (n = 7). The Emory University Institutional Review Board approved the
study and all patients signed informed consent before enrollment.
Anthropometry and body fat composition
Body fat composition was measured by air plethysmography (BOD-POD; Life
Measurement Instruments, Concord, CA) (30). Abdominal fat distribution was measured by
computed tomography, using a GE High Speed Advantage computed tomography scanner
(General Electric Medical Systems, Milwaukee, WI) as described (31). Volumes of visceral
adipose tissue and subcutaneous adipose tissue, respectively, were determined from
computed tomography scans taken from the L1 to the L5 vertebral region (140 kV, 240–340
mA·s, 10 mm slice thickness). Adipose tissue within an attenuation range of −190 to −30
Hounsfield units was highlighted and computed using software (GE Medical Systems,
Waukesha, WI). Body height was measured without shoes. Body weight was measured with
subjects in light clothing, in the fasting state, and immediately after voiding in the morning.
Metabolic measures
Plasma samples were obtained at baseline (before surgery), 1, 6, and 24 months following
surgery and stored at −80 °C. Analysis of plasma 25(OH)D concentrations from baseline, 1,
6, and 24 months were measured in duplicate samples in complete batches using a
commercial human enzyme-linked immunosorbent assay kit (Immunodiagnostics Systems
Laboratory, Scottsdale, AZ). Quality control of the 25(OH)D measurements was assured by
participation in the Vitamin D External Quality Assessment Scheme (www.deqas.org, site
606). The intra- and interassay coefficient of variation of the 25(OH)D measurements were
<8% and <10%, respectively.
Statistical analysis
The statistical software STATISTICA (StatSoft, Tulsa, OK) was used for study analysis.
The differences between time points were analyzed using paired Student’s t-tests and
repeated measures ANOVA. Relationships between 25(OH)D concentrations and secondary
variables, including body FAT, were examined as linear correlations using Pearson
correlations. The significance level for the study was set at P < 0.05 and the results are
expressed as mean ± s.e. of the mean.
RESULTS
Patient characteristics
Twenty patients who underwent RYGB surgery were assessed from baseline to 6 months
following surgery and 10 subjects in this group were analyzed at 24 months following
surgery. The mean age was 33.8 ± 1.7 years (range 24–55). Six women were self-described
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as non-Hispanic African American (AA) in descent, 12 were non-Hispanic–white, and 2
were Hispanic. At baseline, their mean BMI was 48.0 ± 0.9 (range 41.5–55.3). Seven
patients (33% of the population) had diabetes at baseline. Of the patients assessed at 24
months, three were non-Hispanic AA, six were non-Hispanic white and one was Hispanic in
descent.
Changes in adiposity following bariatric surgery
Significant decreases in BMI, and total body fatness were observed at 1 month following
weight loss surgery, and adiposity continued to decrease during 24 months as shown in
Table 1. Similarly, visceral and subcutaneous adipose tissue volumes significantly decreased
compared to baseline at all time points following surgery. There was no difference in BMI at
baseline or in the rate of weight loss in the different race subgroups (data not shown).
Changes in plasma 25-hydroxyvitamin D (25(OH)D) concentrations
Plasma 25(OH)D concentrations were determined for the study population followed for 6
months and the subgroup followed for 24 months. For patients followed for to 6 months post
operatively, there was a transient increase observed in plasma 25(OH)D at 1 month
following surgery (P = 0.002), but values at 6 months were not different from those at
baseline (54.8 ± 5.4, 65.7 ± 6.7, and 61.2 ± 4.6 nmol/l at baseline, 1, and 6 months,
respectively, Figure 1). For the subgroup of subjects followed out to 24 months, plasma
25(OH)D concentrations increased at 1 month (P = 0.004) and then dropped over the
remaining time period such that values at 24 months were significantly decreased (P = 0.02
compared to 1 month); values were 63.8 ± 9.1, 76.9 ± 11.1, 67.7 ± 6.5, 51.1 ± 5.5 nmol/l at
baseline, 1, 6, and 24 months, respectively (Figure 2). A significant effect of time following
surgery on 25(OH)D concentrations was observed (P = 0.02). Plasma 25(OH)D
concentrations in AA subjects were reduced compared to white subjects at baseline, and all
time points following surgery (P < 0.02). Regardless of race subgroup or time point
measured, a high prevalence of vitamin D insufficiency, defined as 25(OH) D <75 nmol/l,
was observed (total population; 76, 71, 67, and 82%, for baseline, 1, 6, and 24 months,
respectively). Similarly, the prevalence of vitamin D deficiency, defined as 25(OH)D <50
nmol/l, was high (total population; 50, 30, 30, and 60% for baseline, 1, 6, and 24 months,
respectively). Vitamin D intake was estimated from 3-day food records obtained from a
subgroup of subjects (n = 7). Compared to baseline vitamin D dietary intake, there were no
changes observed during 6 months following surgery (111.1 ± 37.4, 104.0 ± 32.7, and 149.5
± 58.1 IU at baseline, 1, and 6 months, respectively). For these subjects, a transient increase
in 25-OH-D was observed at 1 month following surgery as was found in the larger
population (54.3 ± 6.5, 72.3 ± 12.3, and 65.9 ± 7.0 nmol/l, at baseline, 1, and 6 months
following surgery). Information on sun exposure was not collected.
Relationships between body fat and serum 25(OH)D concentrations
Cross-sectional and longitudinal associations between body FAT and systemic 25(OH)D
concentrations at baseline and during the 24-month period following surgery were
determined. Significant correlations were observed between adipose tissue mass at baseline
and 25(OH)D concentrations at baseline, 1, and 6 months following surgery (r = 0.68, P =
0.001; r = 0.63, P = 0.003; and r = 0.46, P = 0.04, respectively (Figure 3). The relationships
between baseline adipose tissue and 25(OH)D concentrations became stronger after
adjusting for confounders including age and race subgroup using multiregression analysis
(Table 2). Significant correlations were also found between adipose tissue mass at 1 month
and concentrations of 25(OH)D at 1 and at 6 months following surgery (r = 0.60, P = 0.007;
r = 0.52, P = 0.023, respectively) (Figure 4). These correlations increased after adjustment
for age and race subgroup (Table 3). There were no significant cross-sectional correlations
between adipose tissue mass at 6 and 24 months and systemic 25(OH)D concentrations at
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either of those times (data not shown). Consistent decreases in adipose tissue mass over the
24-month period following surgery did not correspond to changes in plasma 25(OH)D
(Figure 5). In keeping with this observation, longitudinal correlations between changing
adipose tissue mass and changes in 25(OH)D were not significant (correlations between
ΔFAT vs. Δ25(OH)D at 1 and 6 months were r = −0.33, P = 0.16 and r = −0.076, P = 0.75,
respectively). Finally cross-sectional or longitudinal correlations between 25(OH)D
concentrations abdominal visceral or subcutaneous volumes were weak and nonsignificant
(data not shown).
DISCUSSION
The present study demonstrates the early and longer-term impact of RYGB surgery on
vitamin D status as well as relationships between 25(OH)D concentrations and adiposity.
Interestingly, an acute and transient increase in systemic 25(OH)D concentrations was
observed at 1 month followed by a decreasing trend during the remaining 23-months post-
surgery. Before and after surgery, a high prevalence of vitamin D deficiency was found in
both AAs and whites. Finally, strong correlations were demonstrated between adipose tissue
mass and plasma 25(OH)D, which suggest that adipose tissue is a strong contributor to
plasma 25(OH)D concentrations.
The high prevalence of vitamin D deficiency in bariatric surgery patients before and
following surgery is well documented (22–26), but only by a few prospective studies (27–
29). We found similar prevalence of vitamin D deficiency preoperatively (50%) and
postoperatively (30–60%) to what has been reported previously (23,24,29). Only one study
in Sweden, has reported the immediate and longer-term impact of gastric bypass surgery on
vitamin D status in obese individuals (28) and consistent with the present study, they
reported an increase in systemic 25(OH)D at early following surgery. However, in contrast,
the Swedish study found that the increases in 25(OH)D were sustained at 6 months
following RYGB. Potential reasons for the differences between our study and the Swedish
study include that the subjects were superobese (BMI ≥50 kg/ m2) having an average BMI
which was 7.3 points higher than subjects in the present study and subjects increased
vitamin D supplementation following surgery(subjects were prescribed 400 IU vitamin D/
day). However, similar to our study, the Swedish study reported decreased 25(OH)D at 12
months after bariatric surgery. These data taken together suggests that the initial benefits of
surgery on 25(OH)D levels are temporary and do not result in normalization of vitamin D
status in most patients despite achieving lower fat mass. Subjects in the present study had
below recommended intakes of vitamin D (<200 IU/day) and this could be a reason—
independent of gut malabsorption—for the reduced vitamin D status observed over the
longer term following surgery. However, our findings suggest that patients who are
undergoing RYGB should be serially monitored over the longer term as the risk of vitamin
D deficiency increases with time following surgery. Deleterious consequences of low
vitamin D status include increased risk of postoperative infection (32,33), hypertension (34),
and bone density loss (35,36).
Strong correlations that were independent of age and race were observed between adipose
tissue mass at baseline and at 1 month and 25(OH)D concentrations. This finding suggests
that adipose tissue is a strong contributor to vitamin D status. Biochemical analysis of
adipose tissue obtained from humans (19,20) and rodents (18,37) demonstrated that adipose
tissue is a storage depot for vitamin D. Rapid redistribution of vitamin D in adipose tissue
following oral pharmacological dosing, slow release into the systemic circulation, and
accelerated release during weight loss has been shown (18,37). Thus, we speculate that the
increase in plasma 25(OH)D rapidly following RYGB observed in the present study, and in
the study by Aasheim and colleagues (28) may be due to the initial release of vitamin D
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from adipose tissue stores. Using direct measurements of human adipose tissue biopsies
obtained from severely obese individuals, Blum et al. showed strong correlations between
concentrations of 25(OH)D in subcutaneous fat and in serum (20). Although we did not
measure 25(OH)D in adipose tissue directly, our finding of positive relationship among
body FAT and plasma 25(OH)D is consistent with the study by Blum and colleagues (20).
Paradoxically, several studies have shown inverse correlations between adiposity and blood
concentrations of 25(OH)D (13–15,38) and also that obesity is associated with decreased
vitamin D status. An explanation of the discrepancy between the current study finding of a
positive relationship between FAT and circulating 25(OH)D, and the negative relationship
reported by others may be found by examining subjects’ recent energy balance history.
Unlike the latter studies, patients in our study, and in the study by Blum et al., were about to
undergo bariatric surgery. Although our study subjects were currently weight stable at the
time of testing, they are often counseled to undergo weight loss as part of preoperative
preparation and they also may be chronic dieters (39,40). We therefore speculate that
25(OH)D, which has a half-life of 2 months, was released into the circulation during the
preoperative period. Wortsman and colleagues showed that following equal oral intakes of
vitamin D2, lower peak concentrations were observed in obese vs. lean individuals (17).
Thus in patients who are weight stable, dietary or endogenously produced 25(OH)D, which
is lipid-soluble, is sequestered and accumulates in adipose tissue thus limiting its
bioavailability and resulting in a negative association observed between adiposity and
vitamin D status. However, during weight loss and adipose tissue lipolysis, release of
25(OH)D from adipose tissue may occur, which in turn, may contribute to systemic
25(OH)D concentrations. In our study, plasma 25(OH)D concentrations peaked at 1 month
despite continued decrease of adipose tissue over the 24-month postsurgery period, and
correlations between adipose tissue mass and plasma 25(OH)D were only found at earlier
timepoints (baseline and 1 month), but not later time points (6 and 24 months). These
observations suggest that the bioavailability of adipose tissue stores of vitamin D during
weight loss is limited, perhaps due to limited storage or quick release from specific fat
depots that remain to be identified. Although others have reported differential associations
between abdominal visceral and subcutaneous adipose tissue depots and 25(OH)D (41,42),
we did not find these to be substantial in the present study.
The peak of plasma 25(OH)D concentrations in the early phase following RYGB surgery
was followed by a decreasing trend in levels from 6 to 24 months. A decline in vitamin D
status following RYGB has also previously been observed by other studies (23,28) which
may be due to the malabsorptive effects of the procedure. Compliance to vitamin
supplementation regimens has been reported to be low in postbariatric surgery patients (43)
and it is not yet clear from this study or from others (25,28) whether low intake of dietary
vitamin D or malabsorption of vitamin D in the intestine is responsible for the high
prevalence of deficiency following surgery in long-term follow-up. Also some studies have
shown that supplementation of vitamin D at doses close to the recommended daily intakes
(400 IU/day) has not been effective for repletion of vitamin D status in postoperative RYGB
patients (25,44–46).
The strengths of our study were its prospective cohort design with serial determinations
before, and immediately following and during 24 months postgastric bypass in a racially
diverse population. Also, direct measures of body FAT allowed us to determine the
relationship between 25(OH)D concentrations and adiposity during weight loss. Limitations
of our study are the small sample size which included only women, and there was none or
limited information regarding other confounding variables including sun exposure and
dietary vitamin D intake. Although vitamin D deficiency was highly prevalent before and
following surgery, we did not screen for functional consequences such as increased
parathyroid hormone or decreased bone density. Larger prospective studies, which include
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such assessments, information on sun exposure and concomitantly assess adipose tissue and
plasma 25(OH)D concentrations before and after RYGB are needed.
The findings from this study show that patients undergoing gastric bypass surgery are at
high risk for vitamin D deficiency preoperatively and the condition worsens with increasing
time following surgery. Associations between adipose tissue mass and systemic 25(OH)D
concentrations, and a temporary increase acutely following surgery in plasma 25(OH)D
levels were observed. These findings point to increased storage and sequestration of vitamin
D with adiposity and release of vitamin D from adipose tissue during initial weight loss.
This study confirms that vitamin D status further worsens following gastric bypass, which is
a significant concern, given the associations of vitamin D deficiency and the risk of disease
including osteoporosis, cancer, and atherosclerosis.
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Six months changes in plasma 25-hydroxyvitamin D concentrations following surgery. 25-
Hydroxyvitamin D (25(OH)D)) was measured in plasma samples obtained at 0 (before
surgery), and 1, and 6 months following Roux-en-y gastric bypass surgery as described in
Methods and Procedures section. Open squares depicts non-Hispanic white women (n = 12)
and open circles depicts non-Hispanic African-American women (n = 6), the thick line
depicts the averages of total population (n = 20), the thin line depicts the cutoff for normal
vitamin D status (≥75 nmol/l). *Depicts significant different from baseline value (P < 0.05).
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Twenty-four months changes in plasma 25-hydroxyvitamin D concentrations following
surgery. 25-Hydroxyvitamin D (25(OH)D) was measured in plasma samples obtained at 0
(before surgery), and 1, 6, and 24 months following Roux-en-y gastric bypass surgery as
described in Methods and Procedures section. Open squares depicts non-Hispanic white
women (n = 6) and open circles depicts non-Hispanic African-American women (n = 3), the
thick line depicts the averages of total population (n = 10), the thin line depicts the cutoff for
normal vitamin D status (≥75 nmol/l). *Significantly different from baseline value (P <
0.05); †significantly different from 1 month value (P < 0.05).
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Relationship between plasma 25-hydroxyvitamin D and total adiposity before surgery.
Cross-sectional Pearson correlations were determined between total fat mass (FAT) before
surgery (baseline), and 25-hydroxyvitamin D (25(OH)D) at (a) baseline, (b) 1 and (c) 6
months following RYGB (n = 20). FAT, fat mass; RYGB, Roux-en-y gastric bypass.
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Relationship between plasma 25-hydroxyvitamin D and adiposity at 1 month following
surgery. Cross-sectional Pearson correlations were determined between total fat mass (FAT)
at 1 month following surgery and 25-hydroxyvitamin D (25(OH)D) at (a) 1 and (b) 6
months following RYGB (n = 20). RYGB, Roux-en-y gastric bypass.
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Changes in adiposity and 25-hydroxyvitamin D during 24 months following surgery.
Absolute changes, compared to baseline measures, in total adipose tissue mass and 25-
hydroxyvitamin D (25(OH)D) were determined at 1 (Δ1 month, n = 20), 6 (Δ6 months, n =
20) and 24 (Δ24 months, n = 10) months following Roux-en-y gastric bypass surgery.
*Significantly different from baseline value (P < 0.05), †significantly different from 1 month
value (P < 0.05).
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Table 1
Changes in adiposity measures following surgery
Before surgery 1 month post-RYGB 6 month post-RYGB 24 month post-RYGB
BMI (kg/m2) 47.5 ± 0.9 42.8 ± 0.9 33.9 ± 1.1 30.9 ± 2.1
FAT (kg) 70.1 ± 2.2 61.4 ± 2 40.3 ± 2.5 34.2 ± 5.6
VAT (cm3) 4,500 ± 460 3,750 ± 390 2,320 ± 310 1,630 ± 710
SAT (cm3) 13,580 ± 430 12,700 ± 550 8,750 ± 490 6,900 ± 1,080
Body fat mass (BMI), total adipose tissue mass (FAT), and abdominal visceral (VAT), and subcutaneous (SAT) adipose tissue volumes were
measured as described in Methods and Procedures section at 0 (before surgery), and 1, 6 (n = 20), and 24 (n = 10) months following Roux-en-y
gastric bypass (RYGB) surgery. Significant decreases in adiposity were observed at all times following surgery (P < 0.000 compared to the
baseline measure).
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Table 2
Multiple linear regression analysis of relationships between baseline adiposity and 25(OH)D
FAT baseline Model 1 (unadjusted) Model 2 (age, race)
25(OH)Dbaseline 0.68 0.76
25(OH)D1 month 0.63 0.69
25(OH)D6 months 0.46 0.63
Multiple linear regression was performed to assess the effects of age and race as potential confounding variables on the relationships between
baseline adipose tissue mass (FAT) and plasma 25-hydroxyvitamin D concentrations (25(OH)D) at baseline, 1, and 6 months following surgery. β
coefficients are depicted for either unadjusted or adjusted (for age and race) subgroup correlations. All values are significant (P < 0.05).
25(OH)D, 25-hydroxyvitamin D.
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Table 3
Multiple linear regression analysis of relationships between adiposity at 1 month following surgery and
25(OH)D
FAT1 month Model 1 (unadjusted) Model 2 (age, race)
25(OH)D1 month 0.6 0.61
25(OH)D6 months 0.52 0.63
Multiple linear regression was performed to assess the effects of age and race as potential confounding variables on the relationships between 1
month adipose tissue mass (FAT) and 25-hydroxy-vitamin D (25(OH)D) concentrations at 1 and 6 months following surgery. β coefficients are
depicted for either unadjusted or adjusted (for age and race subgroup) correlations. All values are significant, P < 0.05.
Obesity (Silver Spring). Author manuscript; available in PMC 2012 March 1.
